Proscia teams up with Nucleai to improve access to AI biomarkers
Drug Discovery World
JULY 1, 2024
Software company Proscia has partnered with spatial AI biomarker company Nucleai in a collaboration aimed at improving precision medicine biomarkers for clinical trials. The companies are integrating Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and will make them available as part of Proscia’s precision medicine AI portfolio.
Let's personalize your content